Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11746139 IL-7Rαγc binding compounds

Patent 11746139 was granted and assigned to Medikine on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Alice V. Bakker

Ronald W. Barrett

Michael C. Needels

Steven E. Cwirla

William J. Dower

Date of Patent

September 5, 2023

Patent Application Number

17166462

Date Filed

February 3, 2021

Patent Citations

US Patent 10703776 IL-2RBeta binding compounds

US Patent 9861705 Conjugates of an IL-2 moiety and a polymer

US Patent 10035836 Modified IL-2 variants that selectively activate regulatory T cells

US Patent 10689417 IL-2Rγ binding compounds

US Patent 11248030 Dual IL-2R and IL-7R binding compounds

Patent Citations Received

US Patent 11999771 IL-7Rαγc ligand immunoglobulin fusion proteins

0

US Patent 11965015 IL-7R-α-γ binding compounds

0

Patent Primary Examiner

Sudhakar Katakam

IL-7Rαγc binding compounds and pharmaceutical compositions comprising the IL-7Rαγc binding compounds are disclosed. IL-7Rαγc bonding compounds can act as IL-7R agonists and are useful in treating cancer, viral diseases, autoimmune diseases, and inflammatory diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11746139 IL-7Rαγc binding compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool